Investigational Drug Information for Bicine
✉ Email this page to a colleague
What is the development status for investigational drug Bicine?
Bicine is an investigational drug.
There have been 38 clinical trials for Bicine.
The most recent clinical trial was a Phase 3 trial, which was initiated on June 30th 2007.
The most common disease conditions in clinical trials are Breast Neoplasms, Leukemia, and Leukemia, Myeloid, Acute. The leading clinical trial sponsors are Gruppo Italiano Malattie EMatologiche dell'Adulto, French Innovative Leukemia Organisation, and Assistance Publique - Hôpitaux de Paris.
Summary for Bicine
| US Patents | 0 |
| International Patents | 0 |
| US Patent Applications | 3,600 |
| WIPO Patent Applications | 1,817 |
| Japanese Patent Applications | 1,185 |
| Clinical Trial Progress | Phase 3 (2007-06-30) |
| Vendors | 92 |
Recent Clinical Trials for Bicine
| Title | Sponsor | Phase |
|---|---|---|
| Magrolimab Plus Intensive Chemotherapy in Newly Diagnosed AML or HR-MDS | Gilead Sciences | Phase 2 |
| Magrolimab Plus Intensive Chemotherapy in Newly Diagnosed AML or HR-MDS | Uwe Platzbecker | Phase 2 |
| A Study to Evaluate the Combination of ATX-101 and Platinum-based Chemotherapy | Novotech (Australia) Pty Limited | Phase 1/Phase 2 |
Clinical Trial Summary for Bicine
Top disease conditions for Bicine
Top clinical trial sponsors for Bicine
US Patents for Bicine
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
